BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11185961)

  • 21. A FlashPlate assay for the identification of PARP-1 inhibitors.
    Dillon KJ; Smith GC; Martin NM
    J Biomol Screen; 2003 Jun; 8(3):347-52. PubMed ID: 12857389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DeoxyNAD and deoxyADP-ribosylation of proteins.
    Alvarez-Gonzalez R
    Mol Cell Biochem; 1994 Sep; 138(1-2):213-9. PubMed ID: 7898466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in poly(ADP-ribose) level modulate the kinetics of DNA strand break rejoining.
    Ryabokon NI; Goncharova RI; Duburs G; Hancock R; Rzeszowska-Wolny J
    Mutat Res; 2008 Jan; 637(1-2):173-81. PubMed ID: 17935742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of p53 sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation.
    Mendoza-Alvarez H; Alvarez-Gonzalez R
    J Biol Chem; 2001 Sep; 276(39):36425-30. PubMed ID: 11477085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of simulated microgravity conditions on poly(ADP-ribose) polymerase activity in primary cultures of adult rat hepatocytes.
    Cesarone CF; Pippia P; Demori I; Scarabelli L; Fugassa E
    J Gravit Physiol; 2001 Jul; 8(1):P127-8. PubMed ID: 12650200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoprotective effect of gallotannin in oxidatively stressed HaCaT keratinocytes: the role of poly(ADP-ribose) metabolism.
    Bakondi E; Bai P; Erdélyi K; Szabó C; Gergely P; Virág L
    Exp Dermatol; 2004 Mar; 13(3):170-8. PubMed ID: 14987257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cells.
    Mahrouf-Yorgov M; Marie N; Borderie D; Djelidi R; Bonnefont-Rousselot D; Legrand A; Beaudeux JL; Peynet J
    Metabolism; 2009 Apr; 58(4):525-33. PubMed ID: 19303974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mono(ADP-ribosyl)ation of poly(ADP-ribose)polymerase by cholera toxin.
    Martinez M; Price SR; Moss J; Alvarez-Gonzalez R
    Biochem Biophys Res Commun; 1991 Dec; 181(3):1412-8. PubMed ID: 1764092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAD+ analogs substituted in the purine base as substrates for poly(ADP-ribosyl) transferase.
    Oei SL; Griesenbeck J; Buchlow G; Jorcke D; Mayer-Kuckuk P; Wons T; Ziegler M
    FEBS Lett; 1996 Nov; 397(1):17-21. PubMed ID: 8941705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ca2+, Mg2+-dependent endonuclease and ADP-ribosylation.
    Yoshihara K; Tanaka Y; Kamiya T
    Princess Takamatsu Symp; 1983; 13():183-93. PubMed ID: 6317636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of poly(ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells.
    Marecki JC; McCord JM
    Arch Biochem Biophys; 2002 Jun; 402(2):227-34. PubMed ID: 12051667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory mechanisms of poly(ADP-ribose) polymerase.
    Alvarez-Gonzalez R; Watkins TA; Gill PK; Reed JL; Mendoza-Alvarez H
    Mol Cell Biochem; 1999 Mar; 193(1-2):19-22. PubMed ID: 10331633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TFIIF, a basal eukaryotic transcription factor, is a substrate for poly(ADP-ribosyl)ation.
    Rawling JM; Alvarez-Gonzalez R
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):249-53. PubMed ID: 9164864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action].
    Sukhanova MV; Lavrik OI; Khodyreva SN
    Mol Biol (Mosk); 2004; 38(5):834-47. PubMed ID: 15554186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage.
    Affar el B; Shah RG; Dallaire AK; Castonguay V; Shah GM
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):245-50. PubMed ID: 11756665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PARP activity and NAD concentration in PMC from patients affected by systemic sclerosis and lupus erythematosus.
    Cerboni B; Di Stefano A; Micheli V; Morozzi G; Pompucci G; Sestini S
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):471-5. PubMed ID: 20544540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells.
    Kehe K; Raithel K; Kreppel H; Jochum M; Worek F; Thiermann H
    Arch Toxicol; 2008 Jul; 82(7):461-70. PubMed ID: 18046540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ADP-ribosyl)ation, PARP, and aging.
    Beneke S; Bürkle A
    Sci Aging Knowledge Environ; 2004 Dec; 2004(49):re9. PubMed ID: 15590998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neither energy collapse nor transcription underlie in vitro neurotoxicity of poly(ADP-ribose) polymerase hyper-activation.
    Fossati S; Cipriani G; Moroni F; Chiarugi A
    Neurochem Int; 2007 Jan; 50(1):203-10. PubMed ID: 17052800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism.
    Davidovic L; Vodenicharov M; Affar EB; Poirier GG
    Exp Cell Res; 2001 Aug; 268(1):7-13. PubMed ID: 11461113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.